Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 20Genitourinary 19Lymphoid 9Thoracic 7Gastrointestinal 7Other 6Other hematologic neoplasm 4Head & Neck 3Classical hematology 2Sarcoma 1NET 1Endocrine 1

Conditions

Sarcoma 1336Glioblastoma 493Gliosarcoma 470Osteosarcoma 363Brain Neoplasms 321Central Nervous System Neoplasms 276Astrocytoma 262Dendritic Cell Sarcoma, Interdigitating 258Gastrointestinal Stromal Tumors 251Neoplasms 231Glioma 229Lymphoma 226Neuroblastoma 209Rhabdomyosarcoma 208Breast Neoplasms 204Sarcoma, Ewing 202Recurrence 202Burkitt Lymphoma 198Lymphoma, Non-Hodgkin 196Precursor Cell Lymphoblastic Leukemia-Lymphoma 195Oligodendroglioma 192Melanoma 182Ovarian Neoplasms 175Lymphoma, Large B-Cell, Diffuse 173Neoplasm Metastasis 172Bone Neoplasms 168Lymphoma, Follicular 158Leukemia, Lymphocytic, Chronic, B-Cell 144Lymphoma, Mantle-Cell 143Liposarcoma 143

Interventions

pegfilgrastim 1Vincristine 1Rituximab 1Prednisolone 1Lenalidomide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Heart Failure × Sarcoma × Clear all
NCT06220032 2026-01-05

HO170DLBCL

Stichting Hemato-Oncologie voor Volwassenen Nederland

Phase 3 Recruiting
324 enrolled
LymphoidSarcoma

Heart Failure, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡